RENOVA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Renova, and when can generic versions of Renova launch?
Renova is a drug marketed by Valeant Pharms North and is included in two NDAs.
The generic ingredient in RENOVA is tretinoin. There are twenty-six drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the tretinoin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Renova
A generic version of RENOVA was approved as tretinoin by PADAGIS US on December 24th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for RENOVA?
- What are the global sales for RENOVA?
- What is Average Wholesale Price for RENOVA?
Summary for RENOVA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 140 |
Clinical Trials: | 5 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for RENOVA |
What excipients (inactive ingredients) are in RENOVA? | RENOVA excipients list |
DailyMed Link: | RENOVA at DailyMed |
![RENOVA drug patent expirations Drug patent expirations by year for RENOVA](/p/graph/s/t/RENOVA-patent-expirations.png)
![Drug Prices for RENOVA](/p/graph/drug-price/RENOVA.png)
Recent Clinical Trials for RENOVA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Dwight Owen | Phase 1 |
Oregon Health and Science University | Phase 1 |
OHSU Knight Cancer Institute | Phase 1 |
Pharmacology for RENOVA
Drug Class | Retinoid |
US Patents and Regulatory Information for RENOVA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 021108-001 | Aug 31, 2000 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for RENOVA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 021108-001 | Aug 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | ⤷ Sign Up | ⤷ Sign Up |
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 021108-001 | Aug 31, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for RENOVA
See the table below for patents covering RENOVA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Japan | H01500355 | ⤷ Sign Up | |
World Intellectual Property Organization (WIPO) | 8800466 | ⤷ Sign Up | |
European Patent Office | 0182183 | BELT CHAIN FOR ROOT CROP HARVESTERS | ⤷ Sign Up |
Canada | 1303996 | METHODES DE TRAITEMENT DE LA PEAU HUMAINE ALTEREE PAR LE SOLEIL A L'AIDE DE RETINOIDES (METHODS FOR TREATMENT OF SUNDAMAGED HUMAN SKIN WITH RETINOIDS) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for RENOVA
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1304992 | SPC/GB13/061 | United Kingdom | ⤷ Sign Up | PRODUCT NAME: CLINDAMYCIN PHOSPHATE IN COMBINATION WITH TRETINOIN.; REGISTERED: IE PA1332/043/001 20130322; UK PL15142/0249 20130624 |
1304992 | 1390049-3 | Sweden | ⤷ Sign Up | PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322 |
0617614 | C300043 | Netherlands | ⤷ Sign Up | PRODUCT NAME: ALITRETINOIN; NAT. REGISTRATION NO/DATE: EU/1/00/149/001 20001011; FIRST REGISTRATION: EU/1/00/149/001 20001011 |
0617614 | 2001/009 | Ireland | ⤷ Sign Up | PRODUCT NAME: PANRETIN-ALITRETINOIN |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |